Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5492038 | 0.89 | USP2 (0.48) | MMP9KDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL7224666 | 0.87 | USP2 (0.50) | MMP9KDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL7220587 | 0.85 | USP2 (0.54) | MMP9KDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL5671896 | 0.81 | CA2 (0.34) | MMP9CA2CA1F2PRSS1 | |
| SCHEMBL8729658 | 0.81 | CA2 (0.37) | MMP9CA2CA1MMP1MMP2 | |
| SCHEMBL2959329 | 0.81 | CA2 (0.37) | MMP9CA2CA1MMP1MMP2 | |
| SCHEMBL28603425 | 0.81 | CA2 (0.42) | CA2CA1 | |
| SCHEMBL7672107 | 0.78 | CA2 (0.37) | CA2CA1 | |
| SCHEMBL22673043 | 0.78 | TSHR (0.54) | MMP9KDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL7254414 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11491244-B2 | Labeled fluorocarbon agents for positron emission tomography imaging | Sunnybrook Research Institute (CA) | 2022-11-08 | — | — | US | disclosed |
| US-20090297454-A1 | Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use | SCHIRMER HEIKO | 2009-12-03 | — | — | US | disclosed |
| US-7618957-B2 | 1-N-(Benzyloxycarbonyl)-1H,1H,2H,2H,4H,4H,5H,5H-3-aza-perfluorotridecylamine; used in NMR and x-ray diagnosis, radiodiagnosis, and radiotherapy, as well as in MRT lymphography and in blood-pool imaging | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-11-17 | — | — | US | disclosed |
| US-20070189969-A1 | Perfluoroalkyl-containing complexes, process for their production as well as their use | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070189969-A1 | Perfluoroalkyl-containing complexes, process for their production as well as their use | AFF1, FGB, PF4 | MMP9 2634/4885KDM4E 4451/4885USP2 3199/4885 |
| US-20090297454-A1 | Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use | AFF1, FGB, PF4 | MMP9 2634/4885KDM4E 4451/4885USP2 3199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.